HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

9- (5',5'- difluoro- 5'- phosphonopentyl)- 9- deazaguanine

structure in first source

Also Known As:

DFPP-DG

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purinones: 2
        Hypoxanthines: 1
        Guanine: 1793
        9-(5',5'-difluoro-5'-phosphonopentyl)-9-deazaguanine: 1
Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - 9-(5',5'-difluoro-5'-phosphonopentyl)-9-deazaguanine: 1

Experts

1.	Breer, Katarzyna: 1 article (04/2010)
2.	Bzowska, Agnieszka: 1 article (04/2010)
3.	Glavas-Obrovac, Ljubica: 1 article (04/2010)
4.	Hashimoto, Mariko: 1 article (04/2010)
5.	Hikishima, Sadao: 1 article (04/2010)
6.	Magnowska, Lucyna: 1 article (04/2010)
7.	Suver, Mirjana: 1 article (04/2010)
8.	Wielgus-Kutrowska, Beata: 1 article (04/2010)
9.	Yokomatsu, Tsutomu: 1 article (04/2010)

Related Diseases

1.	Lymphoma (Lymphomas) 04/01/2010 - "At a concentration of 10(-4) m, DFPP-DG exhibits weak, but statistically significant, inhibition of the growth of cell lines sensible to inhibition of PNP activity, such as human adult T-cell leukaemia and lymphoma (Jurkat, HuT78 and CCRF-CEM). "